Assenagon Asset Management’s Pacific Biosciences PACB Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-213,091
| Closed | -$390K | – | 1272 |
|
2024
Q4 | $390K | Sell |
213,091
-68,796
| -24% | -$126K | ﹤0.01% | 1204 |
|
2024
Q3 | $479K | Sell |
281,887
-1,013,416
| -78% | -$1.72M | ﹤0.01% | 1210 |
|
2024
Q2 | $1.77M | Buy |
+1,295,303
| New | +$1.77M | ﹤0.01% | 923 |
|
2024
Q1 | – | Sell |
-3,041,624
| Closed | -$29.8M | – | 1409 |
|
2023
Q4 | $29.8M | Buy |
3,041,624
+2,909,439
| +2,201% | +$28.5M | 0.08% | 179 |
|
2023
Q3 | $1.1M | Buy |
+132,185
| New | +$1.1M | ﹤0.01% | 989 |
|
2023
Q2 | – | Sell |
-11,292
| Closed | -$131K | – | 1387 |
|
2023
Q1 | $131K | Sell |
11,292
-238,838
| -95% | -$2.77M | ﹤0.01% | 1337 |
|
2022
Q4 | $2.05M | Sell |
250,130
-545
| -0.2% | -$4.46K | 0.01% | 774 |
|
2022
Q3 | $1.46M | Hold |
250,675
| – | – | 0.01% | 790 |
|
2022
Q2 | $1.11M | Buy |
+250,675
| New | +$1.11M | ﹤0.01% | 1023 |
|
2022
Q1 | – | Sell |
-48,822
| Closed | -$999K | – | 1470 |
|
2021
Q4 | $999K | Buy |
48,822
+16,281
| +50% | +$333K | ﹤0.01% | 995 |
|
2021
Q3 | $831K | Sell |
32,541
-47,457
| -59% | -$1.21M | ﹤0.01% | 910 |
|
2021
Q2 | $2.8M | Sell |
79,998
-543,073
| -87% | -$19M | 0.01% | 570 |
|
2021
Q1 | $20.8M | Sell |
623,071
-12,997
| -2% | -$433K | 0.08% | 188 |
|
2020
Q4 | $16.5M | Sell |
636,068
-234,203
| -27% | -$6.08M | 0.07% | 150 |
|
2020
Q3 | $8.59M | Sell |
870,271
-118,913
| -12% | -$1.17M | 0.05% | 188 |
|
2020
Q2 | $3.41M | Sell |
989,184
-542,166
| -35% | -$1.87M | 0.02% | 410 |
|
2020
Q1 | $4.69M | Buy |
+1,531,350
| New | +$4.69M | 0.04% | 211 |
|
2019
Q4 | – | Sell |
-980,997
| Closed | -$5.06M | – | 849 |
|
2019
Q3 | $5.06M | Buy |
+980,997
| New | +$5.06M | 0.03% | 198 |
|
2019
Q1 | – | Sell |
-116,302
| Closed | -$861K | – | 1021 |
|
2018
Q4 | $861K | Buy |
+116,302
| New | +$861K | 0.01% | 651 |
|